Bionoid Pharma Inc logo

BINP - Bionoid Pharma Inc Share Price

n/a 0.0  0.0%

Last Trade -

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 6651
Bullish
Bearish
Unlock BINP Revenue
Momentum
Relative Strength (%)
1m +2,150%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2006 2007 2008 2009 2010 2011 2012E 2013E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2012, BionoidPharma Inc revenues was not reported. Net loss decreased99% to $57K. Lower net loss reflects Extraordinary item -Gain increase from $0K to $620K (income), Research anddevelopment decrease from $608K (expense) to $0K, Medicaland clinical decrease from $314K (expense) to $0K. BasicEarnings per Share excluding Extraordinary Items increasedfrom -$4.44 to -$0.03.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BINP Revenue Unlock BINP Revenue

Net Income

BINP Net Income Unlock BINP Revenue

Normalised EPS

BINP Normalised EPS Unlock BINP Revenue

PE Ratio Range

BINP PE Ratio Range Unlock BINP Revenue

Dividend Yield Range

BINP Dividend Yield Range Unlock BINP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BINP EPS Forecasts Unlock BINP Revenue
Profile Summary

Bionoid Pharma Inc., formerly Bronya International Corp., is a medical device company. The Company develops and markets medical devices and technologies for the orthopedic and pain management markets. The Company develops and commercializes a platform called muscle pattern recognition (MPR), a clinical tool for the analysis of muscle function in patients presenting with back pain. MPR provides information regarding muscle recruitment patterns in patients suffering from neck and back pain that can assist healthcare professionals in the evaluation and treatment of neck and back injuries and illnesses. The Company, through BIOflex Medical Magnetics, Inc., develops and sells magnetic therapy devices. The Company sells its products through several channels, including Web-based sales; corporate partnerships; direct response television (DRTV); retail distribution; Internet catalogs, and through a network of distributors across the world.

Directors
Last Annual December 31st, 2011
Last Interim September 30th, 2012
Incorporated June 27, 2006
Public Since February 4, 1998
No. of Shareholders: 290
No. of Employees: 13
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 2,442,397
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BINP Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BINP
Upcoming Events for BINP
Frequently Asked Questions for Bionoid Pharma Inc
What is the Bionoid Pharma Inc share price?

As of , shares in Bionoid Pharma Inc are trading at n/a, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Bionoid Pharma Inc share price performed this year?

Shares in Bionoid Pharma Inc are currently trading at n/a and the price has moved by 2.20k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bionoid Pharma Inc price has moved by 1.69k% over the past year.

What are the analyst and broker recommendations for Bionoid Pharma Inc?

There are no analysts currently covering Bionoid Pharma Inc.

When will Bionoid Pharma Inc next release its financial results?

Bionoid Pharma Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2013-09-30
What is the Bionoid Pharma Inc dividend yield?

Bionoid Pharma Inc does not currently pay a dividend.

Does Bionoid Pharma Inc pay a dividend?

Bionoid Pharma Inc does not currently pay a dividend.

When does Bionoid Pharma Inc next pay dividends?

Bionoid Pharma Inc does not currently pay a dividend.

How do I buy Bionoid Pharma Inc shares?

To buy shares in Bionoid Pharma Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bionoid Pharma Inc?

Shares in Bionoid Pharma Inc are currently trading at n/a, giving the company a market capitalisation of £n/a.

Where are Bionoid Pharma Inc shares listed? Where are Bionoid Pharma Inc shares listed?

Here are the trading details for Bionoid Pharma Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: BINP
What kind of share is Bionoid Pharma Inc?

We were not able to load our ranking data for Bionoid Pharma Inc

Is there a Bionoid Pharma Inc share price forecast 2021?

We were not able to load any forecast data for Bionoid Pharma Inc.

How can I tell whether the Bionoid Pharma Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bionoid Pharma Inc. Over the past six months, the relative strength of its shares against the market has been 1.62k%. At the current price of n/a, shares in Bionoid Pharma Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bionoid Pharma Inc PE Ratio?

We were not able to find PE ratio data for Bionoid Pharma Inc.

Who are the key directors of Bionoid Pharma Inc?

Bionoid Pharma Inc's management team is headed by:

Craig Lunsman - DRC
Warren Baker - CHM
Robert Gradus - CFO
Karin Monster - DRC
Mark Tauscher - DRC
Kenneth Aebi - DRC
Gail Gannon - DRC
Who are the major shareholders of Bionoid Pharma Inc?

Here are the top five shareholders of Bionoid Pharma Inc based on the size of their shareholding:

Similar to BINP
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.